Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design

The value of guided therapy (GT) with anti-P2Y12 drugs in percutaneous coronary intervention (PCI) is unclear. Meta-analyses lumped together randomized controlled trials (RCTs) with heterogeneous designs, comparing either genotype-GT or platelet function test (PFT)-GT with unguided therapy. Some met...

Celý popis

Podrobná bibliografia

Vydané v:	Thrombosis and haemostasis Ročník 124; číslo 5; s. 482
Hlavní autori:	Birocchi, Simone, Rocchetti, Matteo, Minardi, Alessandro, Podda, Gian Marco, Squizzato, Alessandro, Cattaneo, Marco
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Germany 01.05.2024
Predmet:	Blood Platelets - drug effects Coronary Artery Disease - therapy Genotype Hemorrhage - chemically induced Humans Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Platelet Function Tests Purinergic P2Y Receptor Antagonists - adverse effects Purinergic P2Y Receptor Antagonists - therapeutic use Randomized Controlled Trials as Topic Receptors, Purinergic P2Y12 Treatment Outcome
ISSN:	2567-689X, 2567-689X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!